Thermo Fisher Scientific Inc. balance sheet
At the end of its fiscal year on Dec 31, 2025, Thermo Fisher Scientific Inc. reported total assets of $110.34B and shareholders' equity of $53.41B. That works out to a current ratio of 1.89 (current assets ÷ current liabilities), long-term debt of 0.73× shareholders' equity.
Balance sheet at each fiscal year end
| Fiscal year ended | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $45.91B | $56.67B | $56.23B | $58.38B | $69.05B | $95.12B | $97.15B | $98.73B | $97.32B | $110.34B |
| Current assets | $7.02B | $9.42B | $10.62B | $11.89B | $21.96B | $20.11B | $25.23B | $24.59B | $22.14B | $28.71B |
| Cash & equivalents | $786.00M | $1.33B | $2.10B | $2.40B | $10.32B | $4.48B | $8.52B | $8.08B | $4.01B | $9.85B |
| Current liabilities | $4.87B | $7.05B | $6.15B | $6.20B | $10.30B | $13.44B | $17.01B | $14.01B | $13.33B | $15.19B |
| Long-term debt | — | — | $17.72B | $17.08B | $19.11B | $34.67B | $34.28B | $34.73B | $31.07B | $39.17B |
| Shareholders' equity | $21.54B | $25.41B | $27.59B | $29.68B | $34.51B | $40.79B | $43.98B | $46.73B | $49.58B | $53.41B |
| Reported in | 10-K 2019 | 10-K 2020 | 10-K 2021 | 10-K 2022 | 10-K 2023 | 10-K 2024 | 10-K 2025 | 10-K 2026 | 10-K 2026 | 10-K 2026 |
Balance-sheet figures are point-in-time values on the last day of each fiscal year. Some companies (for example banks and insurers) do not present current assets and liabilities; those cells show —.
Source: SEC EDGAR XBRL company facts for CIK 97745 (raw data). Most recent filing in this dataset: 10-Q filed Oct 30, 2026. SEC data file dated Nov 3, 2026; page built Nov 5, 2026. Figures are as most recently reported, including restatements. How we select figures.